I am pregnant, can I apply FRONTLINE Plus / FRONTLINE Spot On to my pet?
There are no known health risks associated with applying FRONTLINE Plus or FRONTLINE Spot On to your pet during pregnancy. As a general rule it is good practice to avoid direct contact with any chemicals during pregnancy.
FREQUENTLY ASKED QUESTIONS
EXPERT CARE YOU CAN TRUST
Discover the science and veterinary expertise that continue to put FRONTLINE ahead of the pack.
As the global leaders in pet healthcare, we’re passionate about providing your pet with the best of care
Our high quality parasiticide products are clinically proven to be effective and are highly recommended by pet healthcare professionals
Tried and trusted by pet owners like you, FRONTLINE has satisfaction ratings in excess of 97%*
ALL YOU NEED TO KNOW
Fighting fleas, troubled by ticks or looking for advice from the experts to keep your pet in peak condition?
1 Compared to next leading non-prescription competitor brand and when used monthly.
2 Compared to next leading non-prescription brand with repellent activity.
FRONTLINE Plus® contains fipronil and (S)-methoprene. UK: AVM-GSL. FRONTLINE Tri-Act® contains fipronil and permethrin. UK: NFA-VPS. FRONTLINE® Spot On contains fipronil. UK: AVM-GSL. VELOXA® contains febantel, praziquantel and pyrantel. Anthelmintic for treatment of mixed infections with roundworms and tapeworms in dogs. UK: NFA-VPS. For information about side effects, precautions, warnings and contraindications please refer to the product packaging and package leaflet. Further information available in the SPC or from Boehringer Ingelheim Animal Health UK Ltd, RG12 8YS, UK. Email: petsUK@boehringer-ingelheim.com. Use Medicines Responsibly. FRONTLINE HomeGard® is a biocide. Use biocides safely. Always read the label and product information before use. FRONTLINE Plus®, FRONTLINE Tri-Act®, FRONTLINE®, FRONTLINE HomeGard® and VELOXA® are registered trademarks of the Boehringer Ingelheim Group. ©2021 Boehringer Ingelheim Animal Health UK Ltd. All rights reserved. Date of preparation: Oct 2020. UI-PHC-0191-2020.